Prolife Industries (PROLIFE)₹79.80+5.00%Dyes And Pigments
In the Mar 2026 quarter (standalone), Prolife Industries reported sales of ₹25.82 Cr, down 10.4% from Mar 2025, and net profit of ₹2.77 Cr, up 197.8% year on year. For the year to Mar 2026, sales were ₹54.62 Cr and net profit ₹4.27 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 35.39 | 29.92 | 27.02 | 26.74 | 28.83 | 28.81 | 25.82 |
| Expenses | 31.25 | 22.98 | 22.14 | 21.63 | 28.29 | 26.68 | 23.87 |
| Operating Profit | 4.20 | 6.92 | 4.87 | 5.09 | 0.56 | 2.13 | 1.95 |
| OPM % | 12.0% | 23.2% | 18.1% | 19.1% | 2.0% | 7.5% | 7.6% |
| Other Income | 1.32 | 0.50 | 1.07 | 0.44 | 1.62 | 0.54 | 2.28 |
| Interest | 0.02 | 0.19 | 0.12 | 0.17 | 0.14 | 0.08 | 0.00 |
| Depreciation | 0.64 | 0.63 | 0.60 | 0.57 | 0.55 | 0.60 | 0.41 |
| Profit before tax | 4.89 | 6.63 | 5.25 | 4.82 | 1.52 | 2.02 | 3.86 |
| Tax % | 28.9% | 25.1% | 27.5% | 21.8% | 38.4% | 25.9% | 28.3% |
| Net Profit | 3.47 | 4.97 | 3.82 | 3.76 | 0.93 | 1.50 | 2.77 |
| EPS (Rs) | 8.46 | 12.12 | 9.27 | 9.15 | 2.26 | 3.65 | 6.75 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 19.60 | 22.23 | 27.16 | 27.24 | 29.61 | 50.49 | 73.57 | 73.17 | 78.21 | 56.93 | 55.42 | 54.62 |
| Expenses | 17.80 | 20.43 | 24.68 | 23.73 | 25.45 | 44.95 | 65.46 | 67.33 | 69.64 | 45.13 | 49.79 | 50.55 |
| Operating Profit | 1.81 | 1.79 | 2.53 | 3.54 | 4.19 | 5.55 | 8.21 | 5.97 | 8.73 | 11.80 | 5.67 | 4.09 |
| OPM % | 9.3% | 8.1% | 9.4% | 13.1% | 14.3% | 11.1% | 11.2% | 8.2% | 11.2% | 20.8% | 10.3% | 7.6% |
| Other Income | 0.30 | 0.44 | 0.09 | 0.26 | 0.45 | 1.77 | 0.61 | 1.62 | 2.17 | 1.58 | 2.07 | 2.83 |
| Interest | 1.10 | 1.00 | 0.83 | 0.83 | 0.90 | 0.62 | 0.51 | 0.47 | 0.42 | 0.32 | 0.33 | 0.08 |
| Depreciation | 0.41 | 0.43 | 0.48 | 0.90 | 0.94 | 1.04 | 0.94 | 1.17 | 1.26 | 1.22 | 1.11 | 0.99 |
| Profit before tax | 0.63 | 0.83 | 1.34 | 2.10 | 2.83 | 5.69 | 7.40 | 5.98 | 9.25 | 11.88 | 6.33 | 5.88 |
| Tax % | 37.1% | 35.4% | 33.9% | 28.2% | 28.0% | 28.9% | 25.6% | 28.0% | 25.1% | 26.2% | 25.8% | 27.4% |
| Exceptional items | 0.00 | −0.03 | 0.00 | 0.01 | 0.00 | 0.04 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Profit | 0.41 | 0.54 | 0.88 | 1.51 | 2.05 | 4.05 | 5.52 | 4.31 | 6.93 | 8.80 | 4.69 | 4.27 |
| EPS (Rs) | 2.69 | 3.56 | 2.14 | 3.67 | 4.99 | 9.88 | 13.45 | 10.51 | 16.90 | 21.39 | 11.44 | 10.39 |
| Dividend payout % | 9.0% | 7.0% | 9.4% | 6.9% | 6.0% | 3.1% | 2.2% | 2.9% | 1.8% | 2.3% | 2.6% | 2.9% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 1.50 | 1.48 | 4.09 | 4.08 | 4.10 | 4.08 | 4.10 | 4.10 | 4.09 | 4.10 | 4.09 | 4.09 |
| Reserves | 1.53 | 2.09 | 4.59 | 5.99 | 8.03 | 11.90 | 17.26 | 21.44 | 28.28 | 36.90 | 41.44 | 45.56 |
| Borrowings | 10.12 | 8.63 | 5.09 | 4.83 | 7.15 | 7.72 | 5.50 | 4.72 | 1.93 | 3.82 | 2.58 | 0.28 |
| Other Liabilities | 4.59 | 3.86 | 4.79 | 6.26 | 7.45 | 12.00 | 21.85 | 25.27 | 6.91 | 7.16 | 5.30 | 4.54 |
| Total Liabilities | 17.74 | 16.06 | 18.56 | 21.16 | 26.73 | 35.70 | 48.71 | 55.53 | 41.21 | 51.98 | 53.41 | 54.47 |
| Fixed Assets | 2.74 | 3.20 | 8.12 | 9.57 | 10.05 | 9.61 | 9.35 | 11.44 | 11.35 | 11.30 | 10.50 | 7.88 |
| CWIP | 0.14 | 0.58 | 0.54 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 2.88 | 2.82 | 1.53 | 1.78 | 1.77 | 1.23 | 1.23 | 1.23 | 1.22 | 1.22 | 1.22 | 3.57 |
| Other Assets | 11.98 | 9.46 | 8.37 | 9.81 | 14.91 | 24.86 | 38.13 | 42.86 | 28.64 | 39.46 | 41.69 | 43.02 |
| Inventories | 6.28 | 3.25 | 2.48 | 3.44 | 1.98 | 6.51 | 7.95 | 11.46 | 5.81 | 5.61 | 6.75 | 9.42 |
| Trade receivables | 3.35 | 3.88 | 4.27 | 2.85 | 8.13 | 7.19 | 15.79 | 16.78 | 10.60 | 5.35 | 8.47 | 10.73 |
| Cash & equivalents | 0.48 | 0.35 | 0.28 | 1.00 | 1.10 | 2.67 | 0.84 | 1.38 | 1.47 | 21.56 | 17.43 | 16.13 |
| Total Assets | 17.74 | 16.06 | 18.56 | 21.16 | 26.73 | 35.70 | 48.71 | 55.53 | 41.21 | 51.98 | 53.41 | 54.47 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 0.03 | 4.16 | −0.09 | 5.85 | 0.82 | 10.05 | 5.12 | 3.74 | 0.06 | 17.39 | 0.34 | −1.65 |
| Cash from investing activity | −0.18 | −1.42 | −3.29 | −3.28 | −2.34 | −4.70 | −5.65 | −3.06 | 1.47 | 3.50 | −2.77 | 2.67 |
| Cash from financing activity | 0.48 | −2.87 | 3.31 | −1.87 | 1.64 | −3.75 | −1.32 | −0.15 | −1.44 | −0.73 | −1.70 | −2.33 |
| Net cash flow | 0.32 | −0.12 | −0.05 | 0.70 | 0.09 | 1.57 | −1.83 | 0.53 | 0.07 | 20.04 | −4.11 | −1.30 |
| Capex | 0.83 | 1.32 | 2.81 | 3.07 | 1.39 | 0.61 | 0.77 | 3.24 | 1.12 | 1.16 | 0.33 | 0.94 |
| Free cash flow | −0.83 | 2.83 | −2.91 | 4.05 | −0.60 | 9.47 | 4.46 | 0.49 | −1.09 | 16.24 | 0.02 | −2.57 |
| CFO / OP % | 15.1% | 249.0% | 17.0% | 180.0% | 38.1% | 210.0% | 85.1% | 91.0% | 27.0% | 173.0% | 35.0% | −1.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 64 | 65 | 59 | 39 | 101 | 53 | 79 | 85 | 51 | 35 | 57 | 73 |
| Inventory days | 171 | 69 | 43 | 65 | 37 | 63 | 52 | 77 | 39 | 64 | 68 | 96 |
| Days payable | 90 | 68 | 71 | 103 | 104 | 89 | 123 | 149 | 25 | 37 | 29 | 20 |
| Cash conversion cycle | 142 | 64 | 29 | −1 | 33 | 25 | 6 | 11 | 63 | 60 | 94 | 147 |
| Working capital days | 88 | 40 | 54 | 18 | 55 | 0 | 9 | 20 | 58 | 29 | 70 | 110 |
| ROCE % | 13.6% | 14.9% | 16.5% | 20.3% | 21.7% | 28.9% | 30.8% | 22.5% | 29.9% | 30.7% | 14.3% | 12.1% |
For the Mar 2026 quarter, Prolife Industries reported sales of ₹25.82 Cr, down 10.4% year on year and net profit of ₹2.77 Cr, up 197.8% year on year. The operating margin was 7.6%.
Prolife Industries' sales for the year to Mar 2026 were ₹54.62 Cr.
Net profit for the year to Mar 2026 was ₹4.27 Cr. Earnings per share over the same trailing period were ₹10.39.
Prolife Industries reported borrowings of ₹0.28 Cr at Mar 2026, against cash and equivalents of ₹16.13 Cr.
Cash from operations was −₹1.65 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹2.57 Cr.